Ginkgo Bioworks Holdings (DNA) Net Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -113.00 |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 220.00 |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -515.00 |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -413.00 |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 5,083.00 |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -7,766.00 |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 1,003.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 18,691.00 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -752,733.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7,766.00 |
| Mar 31, 2026 | -18,617.00 |
| Dec 31, 2025 | 345.00 |
| Sep 30, 2025 | -14,459.00 |
| Jun 30, 2025 | 23,232.00 |
| Mar 31, 2025 | 19,933.00 |
| Dec 31, 2024 | -15,816.00 |
| Sep 30, 2024 | 48,310.00 |
| Jun 30, 2024 | -17,129.00 |
| Mar 31, 2024 | -18,327.00 |
| Dec 31, 2023 | 8,901.00 |
| Sep 30, 2023 | 46,283.00 |
| Jun 30, 2023 | 24,857.00 |
| Mar 31, 2023 | 9,666.00 |
| Dec 31, 2022 | 90,475.00 |
| Sep 30, 2022 | -87,732.00 |
| Jun 30, 2022 | -33,887.00 |
| Mar 31, 2022 | -18,107.00 |
| Dec 31, 2021 | -93,611.00 |
| Sep 30, 2021 | 6,446.00 |